Day: March 2, 2022

Irving Resources Encounters High-Grade Vein Intercepts and Confirms Presence of Extensive Lower Mineralized System at Omui Mine Site, Omu Au-Ag Vein Project, Hokkaido, Japan

Written by Customer Service on March 2, 2022. Posted in Public Companies.

Figure 1 Plan map of Omui Mine Site showing drill traces and assay flags. The section line for Figure 2 is shown in red.Figure 2 Interpretive cross section of holes 21OMI-001 and 21OMI-002. Two levels/episodes of mineralization are evident. The lower system was buried by volcaniclastic material which was, in turn. buried by a rhyolite lava flow. The hydrotherm system re-established itself following these events. Irving believes the lower mineralized system is fertile for discovery and that areas around the Honpi structure could host important precious metal veins.VANCOUVER, British Columbia, March 02, 2022 (GLOBE NEWSWIRE) — Irving Resources Inc. (CSE:IRV; OTCQX: IRVRF) (“Irving” or the “Company”) is pleased to announce recent diamond drilling has encountered high-grade vein intercepts and assays confirm the presence of an...

ISW Holdings Inc. Announces Name and Ticker Symbol Changes to BlockQuarry Corp. (OTC PINK:BLQC)

Written by Customer Service on March 2, 2022. Posted in Public Companies.

HOUSTON, March 02, 2022 (GLOBE NEWSWIRE) — via InvestorWire — BlockQuarry Corp. (OTC PINK:BLQC) (the “Company”), formerly ISW Holdings Inc., is pleased to announce that, effective March 2, 2022, the Company’s ticker symbol on the OTC Markets’ OTC Pink market tier has changed from “ISWH” to its new symbol, “BLQC.” The Company’s name has also changed on OTC Markets to BlockQuarry Corp. The name change previously became effective with the Secretary of State of Nevada as of Aug. 2, 2021. “We believe that our new name better reflects our current primary business strategy of operating in the cryptocurrency mining industry,” said Alonzo Pierce, the Company’s president and chairman, adding, “We are excited to begin trading under our new name and symbol as we look to continue building shareholder value.” About BlockQuarry Corp. BlockQuarry...

Supernus to Participate in Annual Cowen Health Care Conference

Written by Customer Service on March 2, 2022. Posted in Public Companies.

ROCKVILLE, Md., March 02, 2022 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that Jack Khattar, President and CEO of Supernus Pharmaceuticals, will participate in a fireside chat as part of the Cowen 42nd Annual Health Care Conference on Wednesday, March 9, 2022, at 1:30 p.m. ET. A live webcast of the presentation can be accessed by visiting Events & Presentations in the Investor Relations section on the Company’s website at www.supernus.com. An archived replay will be available for 60 days on the Company’s website following the conference. About Supernus Pharmaceuticals Supernus Pharmaceuticals is a biopharmaceutical company focused on developing...

Protara Therapeutics to Participate in Upcoming Investor Conferences

Written by Customer Service on March 2, 2022. Posted in Public Companies.

NEW YORK, March 02, 2022 (GLOBE NEWSWIRE) — Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that management will participate in fireside chats at two upcoming virtual conferences:Cowen 42nd Annual Health Care Conference on March 9, 2022 at 9:10am ET Oppenheimer 32nd Annual Healthcare Conference on March 15, 2022 at 2:00pm ETA live webcast of the fireside chats can be accessed by visiting the Events and Presentations section of the Company’s website: https://ir.protaratx.com. The webcasts will be archived on the Company’s website for 90 days following the presentations. About Protara Therapeutics, Inc. Protara is committed to identifying and advancing transformative therapies for people with cancer and rare...

Profound Medical to Participate in March Investor Conferences

Written by Customer Service on March 2, 2022. Posted in Public Companies.

TORONTO, March 02, 2022 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that management will participate in two investor conferences in March.42nd Annual Cowen Health Care Conference: Profound is scheduled to present virtually on Monday, March 7, 2022 at 10:30 a.m. ET. Raymond James 43rd Annual Institutional Investors Conference: Profound is scheduled to present on Wednesday, March 9, 2022 at 9:50 a.m. ET at the JW Marriott Grande Lakes Orlando Hotel.The presentations will be broadcast live and archived on the Company’s website at www.profoundmedical.com under “Webcasts” in the Investors section. About...

Man Group PLC : Form 8.3 – Oxford Instruments PLC

Written by Customer Service on March 2, 2022. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: Man Group PLC(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Oxford Instruments plc(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken: For an opening position...

Man Group PLC : Form 8.3 – Spectris PLC

Written by Customer Service on March 2, 2022. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: Man Group PLC(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Spectris plc(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken: For an opening position disclosure,...

Laurentian Bank of Canada declares dividend on its common shares

Written by Customer Service on March 2, 2022. Posted in Dividend Reports And Estimates.

MONTREAL, March 02, 2022 (GLOBE NEWSWIRE) — At its meeting held on March 1, 2022, the Board of Directors of the Laurentian Bank of Canada (TSX: LB) (the “Bank”) declared a regular quarterly dividend of 44 cents per share on the common shares payable on May 1, 2022 to the holders of record at the close of business on April 1, 2022. The above-mentioned dividends are designated as eligible dividends for the purposes of the Income Tax Act (Canada) and any similar provincial and territorial legislation. The Bank’s common shares are eligible shares under the Bank’s Shareholder Dividend Reinvestment and Share Purchase Plan (the “Plan”). Consequently, the holders of such shares may elect to reinvest their dividends in newly issued common shares of the Bank. Under the Plan, the Bank has the discretion to either purchase the additional common...

ProMIS Neurosciences’ PMN310 antibody demonstrates significant cognitive benefit in a mouse model of Alzheimer’s disease

Written by Customer Service on March 2, 2022. Posted in Public Companies.

Transgenic mouse model reflects latest scientific understanding of disease – toxic oligomers of amyloid create cognitive deficit TORONTO, Ontario and CAMBRIDGE, Mass., March 02, 2022 (GLOBE NEWSWIRE) — ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins such as toxic oligomers, announced today that PMN310, its lead antibody therapeutic candidate for Alzheimer’s disease (AD), showed a significant cognitive benefit in a widely recognized animal model of AD. The APP/L mouse is a “transgenic” model of AD in which human amyloid-beta oligomers lead to cognitive deficits. In this model, treatment with PMN310 which selectively targets toxic oligomers of amyloid-beta preserved memory using the water maze readout, to the...

OneWater Marine Reaches Agreement to Acquire Denison Yachting

Written by Customer Service on March 2, 2022. Posted in Mergers And Acquisitions.

Acquisition significantly expands superyacht sales, yacht sales, and ancillary yacht services Transaction Highlights:Denison and OneWater saw record yacht and boat sales at the recent Miami International Boat Show Denison is #1 in worldwide superyacht sales and expands capabilities in yacht brokerage, yacht charter, yacht management and crew services Further advances OneWater’s growth and diversification strategy, significantly bolstering product portfolio and customer reach Extends OneWater’s geographic footprint, adding 21 locations across 7 states, allowing for additional market share gains Expected to be immediately accretive to top-line growth, operating margin and earnings per shareBUFORD, Ga., March 02, 2022 (GLOBE NEWSWIRE) — OneWater Marine Inc. (NASDAQ: ONEW) (“OneWater” or “the Company”) announced today that it has...

M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30	31

Day: March 2, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals